A shift in antibiotic prescribing practices is paying off. New research shows that STI rates are declining among gay and bisexual men who have access to doxycycline post-exposure prophylaxis, or DoxyPEP. This matters because it demonstrates that a practical, evidence-backed tool can actually move the needle on transmission rates in communities hit hardest by bacterial STIs.
The findings align with CDC guidance released in 2024 recommending doxycycline within 72 hours after condomless sex to prevent chlamydia, gonorrhea, and syphilis. When taken as directed, doxycycline can reduce the risk of bacterial STI acquisition by up to around 86 percent for certain infections. The data now shows that where access expands, uptake increases, and infection rates respond accordingly.
For men with multiple partners or inconsistent condom use, DoxyPEP fills a real gap. It isn't a replacement for condoms or regular testing, but it's a practical backstop. The falling rates suggest that removing barriers to access, whether through telehealth, transparent pricing, or discreet delivery, actually works. If you've had condomless sex and want to know if you're eligible, a provider can assess your situation and write a prescription within days if appropriate.
At B Brand, DoxyPEP is available as a one-time course for $54, or from $32.14 per course on subscription, with same-week prescriptions written after a quick online review.
Featured Products
Stay current on men's sexual health.
New articles, research updates, and treatment guides delivered to your inbox.
No spam. Unsubscribe anytime.
